{"path":"Images/Pasted image 20240220135907.png","text":"BLOOD PRODUCT | CLINICAL CONDITION TRANSFUSION THRESHOLD Haemoglobin (g/dL] [Pretermfermbomanaemic [12 [chronicoxygendependency [11 |Severepumonarydisease [12-14 [toteanaemiastablepatent [ 7 _ TAcutebloodioss>10%EBV [12 Haemoglobin (g/dL] i 000 ISwbewmt 00 7 [ [nfant/chidcriicallyunwell [ 78 ['nfant/child with perioperaive bleeding | 8 Infant/child with cyanotic congenital heart| 9 | oeeme v namaseooogoncamana | [ [ bone marrow stimulation’ previous CVA] Child with sickle cell disease for major| 9 surgery (aim for 9 — 11g/dL and HbS <30%, <20% for thoracic or neurosurgery Platelets | @ [Platelets (x 10%litre) [Neonatewithbleeding _ [%0 [Sickneonatenotbleedng [30 | [Stableneonatenotbleedng [20 [Stabeinfant>4monthsichid [10 [fantichidicU __ [20 surge i to an invasive procedure control for age Cryoprecipitate Neonate/ child with bleeding or DIC not | Fibrinogen < 1 gliitre rorractad with EED","libVersion":"0.3.2","langs":"eng"}